Ordaos

New York, NY · Founded 2019 · Privately Held (backing)

Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. Ordaos is based in New York, NY and was founded in 2019. Its last reported valuation was $110 million in Nov 2024. It has raised $24.5 million across 6 recorded rounds; the latest was a $337,705 seed round in Feb 2025.

Last reported valuation
$110.0M
Oct 2026
Priced at
—
Total raised
$24.5M
Last round
Seed Round
Feb 2025

Ordaos key facts

as of Oct 2026
  • Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery.
  • Ordaos is valued at approximately $110.0M as of Oct 2026 (last reported valuation).
  • It has raised $24.5M across 6 recorded rounds; the latest was Seed Round ($338K) in Feb 2025.
  • Notable investors include StartX (US), AWS Startups, 2468 Ventures, IAG Capital Partners, SeedFolio — 16 tracked in total.
  • Ordaos has filed 6 Form Ds with the SEC since 2022, most recently Apr 2025 ($338K sold to 3 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$110.0M

Ordaos's last reported valuation, Nov 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Ordaos with a free account
  • ·The complete investor list: 16 names
  • ·Watch Ordaos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ordaos funding rounds

6 rounds
Feb 2025Seed Round$338KSEC filing▮
Aug 2024Seed Round$3.1MSEC filing▮
Dec 2023Seed Round$500KSEC filing▮
Dec 2023Seed Round$332KSEC filing▮
Mar 2023Debt$1.8MSEC filing▮

Ordaos valuation

Ordaos's last reported valuation was $110 million in Nov 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Ordaos raised?

Ordaos has raised $24.5 million across 6 recorded rounds since 2022. The largest was a $500,000 seed round in Dec 2023; the most recent was a $337,705 seed round in Feb 2025.

Ordaos has filed 6 Form Ds with the SEC since 2022, most recently in Apr 2025 ($337,705 sold to 3 investors).

Ordaos investors

16 investors are on record for Ordaos, including StartX (US), AWS Startups, 2468 Ventures and IAG Capital Partners. By type, the record holds 5 venture capital firms and 1 family office. The seed round in Feb 2025 drew 3 investors.

About Ordaos

Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. The company's platform provides an artificial intelligence drug discovery pipeline for researchers to develop novel immunotherapies in oncology and chronic inflammatory disease, enabling medical practitioners to deliver safer and more effective treatments than traditional discovery methods.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2019
Employees
25
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.